Noevir Holdings Co., Ltd.
4928.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$154.56B
Close$
Share Statistics
| Market cap | $154.56 Billion |
|---|---|
| Enterprise Value | $141.01 Billion |
| Dividend Yield | $230.00 (5.08%) |
| Earnings per Share | $235.1 |
| Beta | 0.15 |
| Outstanding Shares | 34,156,207 |
Return
| Return on Equity | 15.67% |
|---|---|
| Return on Assets | 10.88% |
| Return on Invested Capital | 17.39% |
Valuation & Multiples
| P/E Ratio | 19.33 |
|---|---|
| PEG | -255.93 |
| Price to Sales | 2.43 |
| Price to Book Ratio | 3.0 |
| Enterprise Value to Revenue | 2.22 |
| Enterprise Value to EBIT | 12.69 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$15.46 B
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$15.46 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Noevir Holdings Co., Ltd.
1,354 employees
CEO: Takashi Okura Noevir Holdings Co., Ltd. is a diversified Japanese conglomerate involved in the creation, production, and distribution of cosmetics, pharmaceuticals, and health food items. Its operations span a wide international footprint, including k...